Gut immune cells—A novel therapeutical target for cardiovascular disease?

Despite scientific and clinical advances during the last 50 years cardiovascular disease continues to be the main cause of death worldwide. Especially patients with diabetes display a massive increased cardiovascular risk compared to patients without diabetes. Over the last two decades we have learn...

Full description

Bibliographic Details
Main Authors: Naresh Ganesh, Emiel P. C. van der Vorst, Jens Spiesshöfer, Shun He, Mathias Burgmaier, Hannes Findeisen, Michael Lehrke, Filip K. Swirski, Nikolaus Marx, Florian Kahles
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.943214/full